Becton, Dickinson and Co.(BDX)
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- 52-Week Range
- $140.11 – $213.08
- YTD
- -25.84%
- IV Rank (30D)
- 11.67
- Straddle Price
- $8.25
- P/C Vol Ratio
- 0.08
- Market Cap
- $39.7B
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 0.5% and dividend payments are stable.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.49% |
| Beta vs SPY | 1.00 |
| Cost of Equity (CAPM) | 9.99% (VRP-adj) |
| WACC | 8.49% |
| Volatility Risk Premium | +26.2pp (IV − HV30), ERP adj +50bps |
| Effective Tax Rate | 14.2% |
| Rev. Growth (YoY, DCF input) | -10.0% |
| DCF Horizon | 5 years explicit + fade |
| Free Cash Flow (TTM) | $3.1B |
| Return on Equity (TTM) | 4.7% |
| Book / Price | 60.1% — banking bias active (P/B is primary) |
| Gross Margin (TTM) | 46.8% |
| FCF Margin (TTM) | 14.7% |
| Debt / Equity | 0.61 |
| Quality Score | 1/6 — cyclical/struggling (5y DCF) |
| Market-Implied Growth | +2.6% (reverse-DCF on current price) |
| SMA 50 | $148.67 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $146.73 |
| Bollinger Width / SMA20 | 5.2% (drives anchor stability) |
| Net Debt | $13.9B |
| Market Cap | $40B |
| Horizon | Expected α | z Pred | Blended z | Rank % | Active? |
|---|---|---|---|---|---|
| 21d | -6.2% | -1.31 | -0.58 | 69.8% | — |
| 42d | -8.5% | -1.25 | -0.58 | 69.8% | — |
| 63d | -10.9% | -1.55 | -0.58 | 69.8% | — |
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $57.87 | 16% | |
| DDM (Gordon) | $18.86 | 13% | |
| Peer P/E | $96.93 | 4% | median 24.5× · 3 peers |
| Peer EV/EBITDA | $292.89 | 5% | median 16.7× · 3 peers |
| Peer P/B | $250.16 | 6% | median 3.0× · 3 peers |
| Peer P/S | $209.50 | 6% | median 2.8× · 3 peers |
| Market Anchor (SMA50) | $148.67 | 33% | stability 100% (BB-width) |
| Options Expected (B-L 30d) | $141.67 | 16% | 63 strikes · skew +0.92 |
- Industry (SIC)
- SURGICAL & MEDICAL INSTRUMENTS & APPARATUS (3841)
- Exchange
- XNYS
- Market Cap
- $39.7B
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
| Month | Avg Return | Years of Data |
|---|---|---|
| Jan | +3.53% | 23 |
| Feb | -1.28% | 23 |
| Mar | +0.15% | 23 |
| Apr | +0.40% | 23 |
| May | -1.29% | 23 |
| Jun | +0.48% | 23 |
| Jul | +2.66% | 22 |
| Aug | -0.10% | 22 |
| Sep | -1.12% | 23 |
| Oct | -0.20% | 23 |
| Nov | +3.45% | 23 |
| Dec | +1.77% | 23 |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.
Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2024-08-01 | Pre-Market | 5.39% | 1.31% | 0.24x | Within |
| 2024-11-07 | Pre-Market | 5.04% | 5.54% | 1.10x | Exceeded |
| 2025-02-05 | Pre-Market | 4.85% | 3.12% | 0.64x | Within |
| 2025-05-01 | Pre-Market | 6.38% | 17.89% | 2.80x | Exceeded |
| 2025-08-07 | Pre-Market | 7.77% | 8.77% | 1.13x | Exceeded |
| 2025-10-15 | Pre-Market | 2.32% | 0.84% | 0.36x | Within |
| 2026-02-09 | Pre-Market | 7.60% | 1.67% | 0.22x | Within |
| 2026-05-07 | Pre-Market | 6.70% | 5.87% | 0.88x | Within |
- IV Rank (30D)
- 11.67
- IV Rank (7D)
- 11.67
- Avg IV
- 55.7%
- Straddle (30D)
- $8.25
- Straddle (7D)
- $8.25
- P/C Volume
- 0.08
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Enter a ticker to render the implied volatility surface.
Enter a ticker to render the implied volatility smile.
- Beta (1Y vs SPY)
- 0.54
- Correlation (SPY)
- 22.0%
- R²
- 0.05
- Ann. Volatility
- 30.4%
- SPY Volatility
- 12.5%
Low volatility - stock moves less than market
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian | $61.74M | 52.80% | 2026-03-31 |
| 2 | JANE STREET GROUP, LLC Custodian | $11.75M | 10.04% | 2026-03-31 |
| 3 | GOLDMAN SACHS GROUP INC Custodian | $11.10M | 9.49% | 2026-03-31 |
| 4 | CITADEL ADVISORS LLC Custodian | $7.47M | 6.39% | 2026-03-31 |
| 5 | Cubist Systematic Strategies, LLC | $7.36M | 6.29% | 2025-09-30 |
| 6 | WOLVERINE TRADING, LLC Custodian | $7.21M | 6.17% | 2025-09-30 |
| 7 | IMC-Chicago, LLC Custodian | $4.21M | 3.60% | 2026-03-31 |
| 8 | SIMPLEX TRADING, LLC Custodian | $1.47M | 1.26% | 2026-03-31 |
| 9 | Point72 Asset Management, L.P. | $1.31M | 1.12% | 2026-03-31 |
| 10 | TUDOR INVESTMENT CORP ET AL | $581.75K | 0.50% | 2026-03-31 |
| 11 | MILLENNIUM MANAGEMENT LLC Custodian | $550.30K | 0.47% | 2026-03-31 |
| 12 | PEAK6 LLC | $455.97K | 0.39% | 2026-03-31 |
| 13 | Allianz Asset Management GmbH | $408.80K | 0.35% | 2026-03-31 |
| 14 | READYSTATE ASSET MANAGEMENT LP | $345.91K | 0.30% | 2026-03-31 |
| 15 | Walleye Capital LLC | $345.91K | 0.30% | 2026-03-31 |
| 16 | Squarepoint Ops LLC | $204.40K | 0.17% | 2026-03-31 |
| 17 | Point72 (DIFC) Ltd | $149.74K | 0.13% | 2025-09-30 |
| 18 | Walleye Trading LLC | $125.78K | 0.11% | 2026-03-31 |
| 19 | GROUP ONE TRADING LLC Custodian | $78.61K | 0.07% | 2026-03-31 |
| 20 | Qube Research & Technologies Ltd | $62.89K | 0.05% | 2026-03-31 |
| 21 | Volterra Technologies LP | $15.72K | 0.01% | 2026-03-31 |
| 22 | Orion Porfolio Solutions, LLC | $157 | <0.01% | 2026-03-31 |
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian | $29.53M | 43.12% | 2026-03-31 |
| 2 | CITADEL ADVISORS LLC Custodian | $9.92M | 14.49% | 2026-03-31 |
| 3 | Cubist Systematic Strategies, LLC | $7.69M | 11.23% | 2025-09-30 |
| 4 | JANE STREET GROUP, LLC Custodian | $5.55M | 8.10% | 2026-03-31 |
| 5 | WOLVERINE TRADING, LLC Custodian | $4.51M | 6.58% | 2025-09-30 |
| 6 | CSS LLC/IL | $2.04M | 2.98% | 2026-03-31 |
| 7 | Point72 Asset Management, L.P. | $2.00M | 2.92% | 2026-03-31 |
| 8 | IMC-Chicago, LLC Custodian | $1.98M | 2.89% | 2026-03-31 |
| 9 | Walleye Trading LLC | $1.07M | 1.56% | 2026-03-31 |
| 10 | Allianz Asset Management GmbH | $849.04K | 1.24% | 2026-03-31 |
| 11 | Volterra Technologies LP | $518.86K | 0.76% | 2026-03-31 |
| 12 | TUDOR INVESTMENT CORP ET AL | $393.07K | 0.57% | 2026-03-31 |
| 13 | Walleye Capital LLC | $393.07K | 0.57% | 2026-03-31 |
| 14 | CAPSTONE INVESTMENT ADVISORS, LLC | $377.35K | 0.55% | 2026-03-31 |
| 15 | Qube Research & Technologies Ltd | $377.35K | 0.55% | 2026-03-31 |
| 16 | READYSTATE ASSET MANAGEMENT LP | $298.74K | 0.44% | 2026-03-31 |
| 17 | Lido Advisors, LLC | $283.01K | 0.41% | 2026-03-31 |
| 18 | SIMPLEX TRADING, LLC Custodian | $232.38K | 0.34% | 2026-03-31 |
| 19 | LOGAN CAPITAL MANAGEMENT INC | $227.04K | 0.33% | 2026-03-31 |
| 20 | GROUP ONE TRADING LLC Custodian | $188.68K | 0.28% | 2026-03-31 |
| 21 | Point72 (DIFC) Ltd | $56.15K | 0.08% | 2025-09-30 |
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-06-11 | Michael David Garrison | EVP & Pres Med.Essntl&BioPharm | Sell (S) | −1,100 | $151.48 | -$166.6K | EDGAR |
| 2026-06-03 | Thomas E Jr Polen | Chairman, CEO and President | Mixed | — | $136.17 | -$404.5K | EDGAR |
| 2026-06-02 | Peter Menziuso | EVP and President, BDI | Award (A) | +14,258 | — | EDGAR | |
| 2026-05-27 | Michael Feld | EVP, Chief Revenue Officer | Sell (S) | −75 | $147.35 | -$11.1K | EDGAR |
| 2026-05-08 | Vitor Roque | EVP & Chief Financial Officer | Award (A) | +1,721 | — | EDGAR | |
| 2026-05-08 | Carrie L Byington | Director | Grant (A) | +105 RSU | — | EDGAR | |
| 2026-05-08 | Robert Luther Huffines | Director | Grant (A) | +210 RSU | — | EDGAR | |
| 2026-04-28 | Michael Feld | EVP, Chief Revenue Officer | Sell (S) | −74 | $151.94 | -$11.2K | EDGAR |
| 2026-04-06 | Shana Carol Neal | EVP and Chief People Officer | Tax (F) | −1,146 | — | EDGAR | |
| 2026-03-27 | Michael Feld | EVP, Chief Revenue Officer | Sell (S) | −75 | $156.83 | -$11.8K | EDGAR |
| 2026-03-17 | Lanesha Minnix | EVP and General Counsel | Award (A) | +7,492 | — | EDGAR | |
| 2026-03-04 | Pamela L. Spikner | SVP Controller & CAO | Award (A) | +931 | — | EDGAR | |
| 2026-03-04 | Vitor Roque | Interim CFO | Award (A) | +931 | — | EDGAR | |
| 2026-02-27 | Michael Feld | EVP, Chief Revenue Officer | Sell (S) | −75 | $181.84 | -$13.6K | EDGAR |
| 2026-02-18 | BERTRAM L SCOTT | Director | Sell (S) | −953 | $182.61 | -$174.0K | EDGAR |
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | VINCENT A FORLENZA | Chairman, CEO and President | 206,995 | $29.97M | -$30.90M | 33 | 2016-12-23 |
| 2 | HENRY P JR BECTON | Director | 140,311 | $20.31M | -$46.56M | 67 | 2015-11-03 |
| 3 | EDWARD J LUDWIG | Chairman | 135,101 | $19.56M | -$75.58M | 32 | 2012-07-11 |
| 4 | Thomas E Jr Polen | Chairman, CEO and President | 125,680 | $18.19M | -$2.55M | 12 | 2026-06-03 |
| 5 | JOHN R CONSIDINE | Vice Chairman | 96,375 | $13.95M | -$23.77M | 8 | 2009-11-25 |
| 6 | GARY M COHEN | Executive Vice President | 91,944 | $13.31M | -$35.81M | 38 | 2017-01-03 |
| 7 | WILLIAM A KOZY | Executive Vice President | 80,948 | $11.72M | -$26.64M | 32 | 2015-12-09 |
| 8 | TIMOTHY M RING | Director | 61,445 | $8.90M | $0 | 3 | 2026-01-29 |
| 9 | ALFRED JOHN HANSON | Executive Vice President | 50,880 | $7.37M | -$9.88M | 6 | 2008-11-26 |
| 10 | JEFFREY S SHERMAN | Sr. VP and General Counsel | 49,079 | $7.11M | -$20.89M | 34 | 2017-02-16 |
What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. Amendments (Form 144/A) and post-cancellation refilings can inflate this if you sum naively; the rollup above excludes filings with zero stated value.
Source & freshness: Parsed directly from EDGAR primary-doc XML. Daily refresh; new filings typically appear here the morning after they hit EDGAR.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-06-10 | MICHAEL GARRISON | Officer | 1,100 | $167.2K | 2026-06-10 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2026-06-01 | THOMAS POLEN | Officer | 2,764 | $406.6K | 2026-06-01 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2026-05-26 | MICHAEL FELD | Officer | 75 | $11.1K | 2026-05-26 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2026-04-27 | MICHAEL FELD | Officer | 74 | $11.3K | 2026-04-27 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2026-03-26 | MICHAEL FELD | Officer | 75 | $11.9K | 2026-03-26 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2026-02-26 | MICHAEL FELD | Officer | 75 | $13.6K | 2026-02-26 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2026-02-20 | DAVID MICHEL SHAN | Former Officer | 5,422 | $998.4K | 2026-02-20 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2026-02-20 | CHRISTOPHER DELOREFICE | Former Officer | 11,305 | $2.08M | 2026-02-20 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2026-02-18 | CHRISTOPHER DELOREFICE | Former Officer | 9,366 | $1.71M | 2026-02-18 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2026-02-18 | BERTRAM SCOTT | Director | 953 | $174.0K | 2026-02-18 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| Filing Date | Accession | Link |
|---|---|---|
| 2026-05-29 | 0001628280-26-039005 | EDGAR |
| 2026-05-20 | 0001140361-26-022270 | EDGAR |
| 2026-05-12 | 0001140361-26-020828 | EDGAR |
| 2026-05-07 | 0001628280-26-031638 | EDGAR |
| 2026-04-29 | 0000010795-26-000012 | EDGAR |
| 2026-04-09 | 0001628280-26-024472 | EDGAR |
| 2026-04-02 | 0001628280-26-023185 | EDGAR |
| 2026-02-25 | 0001140361-26-006794 | EDGAR |
| 2026-02-10 | 0001140361-26-004601 | EDGAR |
| 2026-02-09 | 0001628280-26-006182 | EDGAR |
| Filing Date | Accession | Link |
|---|---|---|
| 2025-11-25 | 0000010795-25-000099 | EDGAR |
| 2024-11-27 | 0000010795-24-000084 | EDGAR |
| 2023-11-21 | 0000010795-23-000098 | EDGAR |
| 2022-11-22 | 0001628280-22-030686 | EDGAR |
| 2021-11-24 | 0000010795-21-000091 | EDGAR |
| 2020-11-25 | 0000010795-20-000055 | EDGAR |
| 2019-11-27 | 0000010795-19-000044 | EDGAR |
| 2018-11-21 | 0000010795-18-000036 | EDGAR |
| Filing Date | Accession | Link |
|---|---|---|
| 2026-05-07 | 0000010795-26-000026 | EDGAR |
| 2026-02-09 | 0000010795-26-000005 | EDGAR |
| 2025-08-07 | 0000010795-25-000072 | EDGAR |
| 2025-05-01 | 0000010795-25-000039 | EDGAR |
| 2025-02-06 | 0000010795-25-000022 | EDGAR |
| 2024-08-01 | 0000010795-24-000067 | EDGAR |
| 2024-05-02 | 0000010795-24-000039 | EDGAR |
| 2024-02-01 | 0000010795-24-000019 | EDGAR |
| 2023-08-03 | 0000010795-23-000075 | EDGAR |
| 2023-05-04 | 0000010795-23-000039 | EDGAR |
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
| P/E Ratio | 36.6 |
| P/B Ratio | 1.6 |
| P/S Ratio | 1.9 |
| EV/EBITDA | 9.6 |
| TTM Revenue | $21.4B |
| TTM Net Income | $1.1B |
| TTM EPS | $3.95 |
| ROE | 4.7% |
| Dividend Yield | 2.99% |
| Debt/Equity | 0.72 |